These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12604605)
21. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988 [TBL] [Abstract][Full Text] [Related]
22. Nephronectin binds to heparan sulfate proteoglycans via its MAM domain. Sato Y; Shimono C; Li S; Nakano I; Norioka N; Sugiura N; Kimata K; Yamada M; Sekiguchi K Matrix Biol; 2013 Apr; 32(3-4):188-95. PubMed ID: 23357641 [TBL] [Abstract][Full Text] [Related]
23. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment. Cruz LA; Tellman TV; Farach-Carson MC Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656 [TBL] [Abstract][Full Text] [Related]
24. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan. Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28846206 [TBL] [Abstract][Full Text] [Related]
25. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988 [TBL] [Abstract][Full Text] [Related]
26. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142 [TBL] [Abstract][Full Text] [Related]
31. The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy. Douglass S; Goyal A; Iozzo RV Connect Tissue Res; 2015; 56(5):381-91. PubMed ID: 26181327 [TBL] [Abstract][Full Text] [Related]
32. Phospholipid scramblase 1 is secreted by a lipid raft-dependent pathway and interacts with the extracellular matrix protein 1 in the dermal epidermal junction zone of human skin. Merregaert J; Van Langen J; Hansen U; Ponsaerts P; El Ghalbzouri A; Steenackers E; Van Ostade X; Sercu S J Biol Chem; 2010 Nov; 285(48):37823-37. PubMed ID: 20870722 [TBL] [Abstract][Full Text] [Related]
33. Proteoglycans of basement membranes. Timpl R Experientia; 1993 May; 49(5):417-28. PubMed ID: 8500597 [TBL] [Abstract][Full Text] [Related]
34. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells. Vischer P; Feitsma K; Schön P; Völker W Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876 [TBL] [Abstract][Full Text] [Related]
35. The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. Miosge N; Simniok T; Sprysch P; Herken R J Histochem Cytochem; 2003 Mar; 51(3):285-96. PubMed ID: 12588956 [TBL] [Abstract][Full Text] [Related]
36. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Klein G; Conzelmann S; Beck S; Timpl R; Müller CA Matrix Biol; 1995 Feb; 14(6):457-65. PubMed ID: 7795884 [TBL] [Abstract][Full Text] [Related]
37. Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling. Kim HN; Elgundi Z; Lin X; Fu L; Tang F; Moh ESX; Jung M; Chandrasekar K; Bartlett-Tomasetig F; Foster C; Packer NH; Whitelock JM; Rnjak-Kovacina J; Lord MS J Control Release; 2023 Oct; 362():184-196. PubMed ID: 37648081 [TBL] [Abstract][Full Text] [Related]
38. Extracellular matrix protein 1, a direct targeting molecule of parathyroid hormone-related peptide, negatively regulates chondrogenesis and endochondral ossification via associating with progranulin growth factor. Kong L; Zhao YP; Tian QY; Feng JQ; Kobayashi T; Merregaert J; Liu CJ FASEB J; 2016 Aug; 30(8):2741-54. PubMed ID: 27075243 [TBL] [Abstract][Full Text] [Related]
39. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433 [TBL] [Abstract][Full Text] [Related]
40. p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells. Sakai K; Oka K; Matsumoto K; Nakamura T Biochem Biophys Res Commun; 2010 Feb; 392(3):403-8. PubMed ID: 20074558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]